What is the 13F Pro Quality Score for ADTX?

13F Pro ranks Aditxt, Inc. (ADTX) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View ADTX's current score at https://13fpro.ai/research/ADTX (free sign-up required for the full ranking).

Where does 13F Pro source ADTX data?

All Aditxt, Inc. fundamentals and ownership data come directly from SEC EDGAR. Aditxt, Inc. files with the SEC under CIK 1726711. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is ADTX in?

Aditxt, Inc. (ADTX) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is ADTX research updated on 13F Pro?

ADTX's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Aditxt, Inc.(ADTX)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1726711 ADTX stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.9M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

ADTX Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Aditxt, Inc. (ADTX), a Healthcare sector company. ADTX is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.9m in revenue. Based on the latest XBRL financial filings (Q1 2026), Aditxt, Inc. reports quarterly revenue of $12.2K, net income of $-15.9M, free cash flow of $-4.6M. Top institutional holders of ADTX by reported 13-F value include GEODE CAPITAL MANAGEMENT,, MORGAN STANLEY, Tower Research Capital (TRC), based on the most recent SEC filings. ADTX trades on the Nasdaq exchange and files with the SEC under CIK 1726711. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ADTX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Aditxt, Inc. directly from SEC EDGAR.

Revenue

Q1 2026

$12.2K

Net Income

Q1 2026

$-15.9M

Free Cash Flow

Q1 2026

$-4.6M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-97.6% YoY

$3.2KFY 2025

FY22 $933.7KFY23 $645.2KFY24 $134.0KFY25 $3.2K

Net Income

-6.8% YoY

$-43.1MFY 2025

FY22 $-27.6MFY23 $-32.7MFY24 $-40.4MFY25 $-43.1M

Operating Income

+29.8% YoY

$-19.6MFY 2025

FY22 $-25.5MFY23 $-26.1MFY24 $-27.9MFY25 $-19.6M

EPS (Diluted)

+100.0% YoY

$-1153.83FY 2025

FY22 $-319.85FY23 $-27038.26FY24 $-22147415.22FY25 $-1153.83

Total Assets

-48.6% YoY

$16.5MFY 2025

FY22 $10.7MFY23 $44.6MFY24 $32.1MFY25 $16.5M

Op. Cash Flow

-53.3% YoY

$-25.7MFY 2025

FY22 $-22.4MFY23 $-19.2MFY24 $-16.8MFY25 $-25.7M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019
Revenue	$3.2K -97.6%	$134.0K -79.2%	$645.2K -30.9%	$933.7K	—	—
Net Income	$-43.1M -6.8%	$-40.4M -23.4%	$-32.7M -18.3%	$-27.6M -202.2%	$-9.1M -57.0%	$-5.8M
Operating Income	$-19.6M +29.8%	$-27.9M -6.9%	$-26.1M -2.3%	$-25.5M -187.2%	$-8.9M -51.1%	$-5.9M
EPS (Diluted)	$-1153.83 +100.0%	$-22147415.22 -81811.4%	$-27038.26 -8353.3%	$-319.85	—	—
Total Assets	$16.5M -48.6%	$32.1M -27.9%	$44.6M +315.3%	$10.7M -18.0%	$13.1M +10501.7%	$123.5K
Operating Cash Flow	$-25.7M -53.3%	$-16.8M +12.7%	$-19.2M +14.2%	$-22.4M -210.1%	$-7.2M -1455.1%	$-464.4K

AI Insight: ADTX Financial Trends

Pre-revenue biotech burning cash with deteriorating equity position; Q1 2026 equity turned negative at -$33M.

• Revenue remains zero across all periods. Net losses averaged -$10M quarterly through Q1 2026, with Q3 2025 spike to -$24M.

• Operating cash outflow persisted throughout period, ranging -$2M to -$12M per quarter. Q1 2026 CF burn: -$5M.

• Shareholder equity collapsed from $7M (Q2 2024) to -$33M (Q1 2026), signaling cumulative losses exceed tangible assets.

⚠ Negative equity of -$33M indicates technical insolvency; capital raise or major partnership required to continue operations.

⚠ Operating margin near breakeven (-4% to -6%) despite zero revenue suggests development spend stabilizing, but timeline to revenue unknown.

AI Insight: ADTX Ratio Trends

Insufficient financial data to construct a meaningful trend analysis; only ROA figures available and all negative.

• ROA deteriorated from -65.0% in Q4 2024 to -88.8% in Q2 2025, indicating worsening asset efficiency and persistent losses.

⚠ Data gaps prevent assessment of operating margin, net profitability, leverage, and ROIC trends; operational performance unclear.

Get alerted when ADTX's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Aditxt, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of ADTX

GEODE CAPITAL MANAGEMENT, LLC
$11.5K11,721 sh
MORGAN STANLEY
$7.8K8,002 sh
Tower Research Capital LLC (TRC)
$535.00547 sh
DANSKE BANK A/S
$3.003 sh
GROUP ONE TRADING, L.P.
$2.002 sh
IFP Advisors, Inc
$1.001 sh
UBS Group AG
$1.001 sh
Western Wealth Management, LLC
$1.001 sh
Darwin Wealth Management, LLC
$0.001 sh
OSAIC HOLDINGS, INC.
$0.002 sh

Fund	Value	Shares
GEODE CAPITAL MANAGEMENT, LLC	$11.5K	11,721
MORGAN STANLEY	$7.8K	8,002
Tower Research Capital LLC (TRC)	$535.00	547
DANSKE BANK A/S	$3.00	3
GROUP ONE TRADING, L.P.	$2.00	2
IFP Advisors, Inc	$1.00	1
UBS Group AG	$1.00	1
Western Wealth Management, LLC	$1.00	1
Darwin Wealth Management, LLC	$0.00	1
OSAIC HOLDINGS, INC.	$0.00	2

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put ADTX on your watchlist

Track score changes the day Aditxt, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is ADTX a good stock to buy?

13F Pro's AI-powered analysis of Aditxt, Inc. (ADTX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ADTX are available on the ADTX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own ADTX?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ADTX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Aditxt, Inc.'s investment landscape.